We recently published a list of Jim Cramer Discusses These 10 Stocks, The Fed Chair & Lower AI Costs. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other stocks that Jim Cramer discusses along with insights on The Fed Chair & Lower AI Costs.
We recently published a list of 10 AI Stocks Analysts Are Focusing On These Days. In this article, we are going to take a look at where Nvidia Corporation (NASDAQ:NVDA) stands against other AI stocks analysts are focusing on these days.
After a market-wide panic over AI start-up DeepSeek, CNBC’s Jim Cramer reflected on what the new player’s entrance into the arena means for Big Tech.
Monday’s rout reflected the market’s anxiety that if a scrappy open-source Chinese model really can match ChatGPT, AI could be significantly cheaper than previously anticipated.
We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Nvidia (NASDAQ:NVDA) stands against other stocks that Jim Cramer
We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says He’s In Waiting For AI GPU Spending Clarity. In this article, we are going to take a look at where Apple Inc (NASDAQ:AAPL) stands against the other stocks Jim Cramer recently discussed.
'Mad Money' host Jim Cramer recaps Nvidia's down week following the DeepSeek AI shakeup. Trump administration erases mention of climate change and LGBTQ+ health data from key government sites
CNBC’s Jim Cramer on Friday told investors DeepSeek might not pose as serious a threat to Nvidia’s sales as many investors feared this week.
We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a look at where The Walt Disney Company (NYSE:DIS) stands against the other stocks Jim Cramer talked about recently.
We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a look at where Norwegian Cruise Line Holdings Ltd.
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq by $4 billion.